Nova Life Peptides Sells Research Use Only Peptides
Verifying Excellence: The Role of HPLC and MS in Research Peptides
Scientific discovery depends on the reliability of chemical reagents, making analytical verification the backbone of any reputable supplier. Nova Life Peptides understands that in preclinical studies, there is no room for ambiguity. This is why the company utilizes a dual-layered testing approach featuring High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS).
The Precision of HPLC Testing
High-Performance Liquid Chromatography, or HPLC, is the primary tool used to determine the percentage of a target peptide in a sample. By using high pressure to push the compound through a chromatographic column, HPLC can isolate the target peptide from residual solvents or truncated sequences. For Nova Life Peptides, this means ensuring that the here "peak" representing the peptide accounts for nearly the entire sample.
Identity Verification via Mass Spectrometry
While HPLC measures how much of the substance is pure, Mass Spectrometry (MS) confirms that the substance is exactly what it claims to be. By breaking the peptide down and measuring its mass, MS allows researchers to verify the exact amino acid sequence and molecular weight.
The Researcher’s Advantage: Ready-to-Use Data
By providing a Certificate of Analysis (COA) that includes these reports, Nova Life Peptides removes the guesswork from the procurement process. Nova Life Peptides' investment in these technologies ensures that their RUO (Research Use Only) products stand up to the retrospective scrutiny of any peer-review process.